Owner SUMITOMO PHARMACEUTICALS CO., LTD.

Inventors TOKUNAGA, Teruhisa; HUME, William Ewan; KITOH, Makoto; NAGATA, Ryu; KISHINO, Michiko; NAKAGAWA, Tsutomu; NAGAMINE, Jun; TAIJI, Mutsuo

Pub. Number AU-A-2003239586

PCT Number PCT/JP03/00811

PCT Pub. Number WO2003/063861

Priority 2002-021056 30.01.02 JP

Filing date 28 January 2003

Wipo publication date 2 September 2003

A61K 031/381 - having five-membered rings

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 011/00 Drugs for disorders of the respiratory system

A61P 013/12 Drugs for disorders of the urinary system

A61P 017/00 Drugs for dermatological disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 031/404

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 031/415 - 1,2-Diazoles

A61K 031/4155 - not condensed and containing further heterocyclic rings

A61K 031/4174

A61K 031/425 - Thiazoles

A61K 031/427 - not condensed and containing further heterocyclic rings

A61K 031/428 - condensed with carbocyclic rings

A61K 031/4439

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 031/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 031/5377

C07D 207/333 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/12 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 233/64 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 275/02 Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 333/22 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/06 Heterocyclic compounds containing two or more hetero rings